(+)-schisandrin B multiple interactions ISO RGD:620421 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VAMP8 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1347649 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of VAMP8 mRNA CTD PMID:22079256 1,2-dimethylhydrazine multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of VAMP8 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of VAMP8 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of VAMP8 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VAMP8 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:620421 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of VAMP8 mRNA CTD PMID:26496021 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1347649 6480464 Tetrachlorodibenzodioxin results in decreased expression of VAMP8 mRNA CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of VAMP8 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1347649 6480464 Tetrachlorodibenzodioxin results in increased expression of VAMP8 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VAMP8 mRNA CTD PMID:17942748 2-hydroxypropanoic acid decreases expression ISO RGD:1347649 6480464 Lactic Acid results in decreased expression of VAMP8 mRNA CTD PMID:30851411 2-methoxyethanol increases expression ISO RGD:620421 6480464 methyl cellosolve results in increased expression of VAMP8 mRNA CTD PMID:21061450 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis4-hydroxyphenylsulfone results in increased expression of VAMP8 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine affects expression ISO RGD:1347649 6480464 Decitabine affects the expression of VAMP8 mRNA CTD PMID:17145863 acrylamide decreases expression ISO RGD:620421 6480464 Acrylamide results in decreased expression of VAMP8 mRNA CTD PMID:28959563 aflatoxin B1 increases methylation ISO RGD:1347649 6480464 Aflatoxin B1 results in increased methylation of VAMP8 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:1347649 6480464 Tretinoin results in increased expression of VAMP8 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:620421 6480464 Tretinoin results in increased expression of VAMP8 mRNA CTD PMID:20488242 ammonium chloride affects expression ISO RGD:620421 6480464 Ammonium Chloride affects the expression of VAMP8 mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:620421 6480464 Amphetamine results in increased expression of VAMP8 mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1347649 6480464 Antirheumatic Agents results in decreased expression of VAMP8 mRNA CTD PMID:24449571 benzene decreases expression ISO RGD:1347649 6480464 Benzene results in decreased expression of VAMP8 mRNA CTD PMID:20036648 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of VAMP8 mRNA CTD PMID:22228805 benzo[a]pyrene decreases methylation ISO RGD:1347649 6480464 Benzoapyrene results in decreased methylation of VAMP8 5' UTR, Benzoapyrene results in decreased methylation of VAMP8 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1347649 6480464 Benzoapyrene results in increased expression of VAMP8 mRNA CTD PMID:20106945 , PMID:21632981 bexarotene increases expression ISO RGD:1347649 6480464 bexarotene results in increased expression of VAMP8 mRNA CTD PMID:17178900 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1347649 6480464 Diethylhexyl Phthalate results in increased expression of VAMP8 mRNA CTD PMID:31163220 bisphenol A multiple interactions ISO RGD:620421 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of VAMP8 mRNA CTD PMID:26496021 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of VAMP8 mRNA CTD PMID:30951980 bisphenol A affects expression ISO RGD:1347649 6480464 bisphenol A affects the expression of VAMP8 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:620421 6480464 bisphenol A results in decreased expression of VAMP8 mRNA CTD PMID:30816183 bisphenol A affects expression ISO RGD:620421 6480464 bisphenol A affects the expression of VAMP8 mRNA CTD PMID:25181051 bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of VAMP8 mRNA CTD PMID:30951980 chloropicrin increases expression ISO RGD:1347649 6480464 chloropicrin results in increased expression of VAMP8 mRNA CTD PMID:26352163 cisplatin increases expression ISO RGD:1347649 6480464 Cisplatin results in increased expression of VAMP8 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1347649 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of VAMP8 mRNA CTD PMID:27392435 clothianidin increases expression ISO RGD:1347649 6480464 clothianidin results in increased expression of VAMP8 mRNA CTD PMID:31626844 cobalt dichloride decreases expression ISO RGD:1347649 6480464 cobaltous chloride results in decreased expression of VAMP8 mRNA CTD PMID:19376846 copper atom decreases expression ISO RGD:620421 6480464 Copper results in decreased expression of VAMP8 mRNA CTD PMID:30556269 copper(0) decreases expression ISO RGD:620421 6480464 Copper results in decreased expression of VAMP8 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1347649 6480464 Copper Sulfate results in decreased expression of VAMP8 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1347649 6480464 Cyclosporine results in decreased expression of VAMP8 mRNA CTD PMID:20106945 dicrotophos decreases expression ISO RGD:1347649 6480464 dicrotophos results in decreased expression of VAMP8 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1347649 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 elemental selenium increases expression ISO RGD:1347649 6480464 Selenium results in increased expression of VAMP8 mRNA CTD PMID:19244175 entinostat increases expression ISO RGD:1347649 6480464 entinostat results in increased expression of VAMP8 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1347649 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of VAMP8 mRNA CTD PMID:27188386 ethyl methanesulfonate increases expression ISO RGD:1347649 6480464 Ethyl Methanesulfonate results in increased expression of VAMP8 mRNA CTD PMID:23649840 folic acid multiple interactions EXP 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of VAMP8 mRNA] CTD PMID:22206623 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of VAMP8 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1347649 6480464 Formaldehyde results in increased expression of VAMP8 mRNA CTD PMID:23649840 gentamycin increases expression ISO RGD:620421 6480464 Gentamicins results in increased expression of VAMP8 mRNA CTD PMID:22061828 mercury dibromide increases expression ISO RGD:1347649 6480464 mercuric bromide results in increased expression of VAMP8 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1347649 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of VAMP8 mRNA CTD PMID:27188386 methyl methanesulfonate increases expression ISO RGD:1347649 6480464 Methyl Methanesulfonate results in increased expression of VAMP8 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1347649 6480464 methylmercuric chloride results in decreased expression of VAMP8 mRNA CTD PMID:23179753 N-nitrosodiethylamine multiple interactions ISO RGD:620421 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of VAMP8 mRNA more ... CTD PMID:20360939 , PMID:25374375 paclitaxel affects response to substance ISO RGD:1347649 6480464 VAMP8 protein affects the susceptibility to Paclitaxel CTD PMID:16217747 panobinostat increases expression ISO RGD:1347649 6480464 panobinostat results in increased expression of VAMP8 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1347649 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of VAMP8 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:1347649 6480464 Acetaminophen results in decreased expression of VAMP8 mRNA CTD PMID:21420995 , PMID:29067470 phenethyl caffeate multiple interactions ISO RGD:620421 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of VAMP8 mRNA CTD PMID:20360939 phenobarbital affects expression ISO RGD:1347649 6480464 Phenobarbital affects the expression of VAMP8 mRNA CTD PMID:19159669 phenobarbital multiple interactions ISO RGD:620421 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of VAMP8 mRNA, [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of VAMP8 promoter CTD PMID:25374375 phenylmercury acetate increases expression ISO RGD:1347649 6480464 Phenylmercuric Acetate results in increased expression of VAMP8 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1347649 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of VAMP8 mRNA CTD PMID:27188386 potassium chromate multiple interactions ISO RGD:1347649 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of VAMP8 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1347649 6480464 potassium chromateVI results in decreased expression of VAMP8 mRNA CTD PMID:22079256 rac-lactic acid decreases expression ISO RGD:1347649 6480464 Lactic Acid results in decreased expression of VAMP8 mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:1347649 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 selenium atom increases expression ISO RGD:1347649 6480464 Selenium results in increased expression of VAMP8 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO RGD:1347649 6480464 Silicon Dioxide analog results in decreased expression of VAMP8 mRNA CTD PMID:25895662 tetrachloromethane decreases expression ISO RGD:620421 6480464 Carbon Tetrachloride results in decreased expression of VAMP8 mRNA CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of VAMP8 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions ISO RGD:620421 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of VAMP8 mRNA] CTD PMID:31150632 toluene decreases expression ISO RGD:620421 6480464 Toluene results in decreased expression of VAMP8 mRNA CTD PMID:22967744 trichostatin A increases expression ISO RGD:1347649 6480464 trichostatin A results in increased expression of VAMP8 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1347649 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of VAMP8 mRNA CTD PMID:27188386 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of VAMP8 mRNA CTD PMID:16141432 valproic acid decreases expression ISO RGD:1347649 6480464 Valproic Acid results in decreased expression of VAMP8 mRNA CTD PMID:29154799 valproic acid multiple interactions ISO RGD:1347649 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of VAMP8 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1347649 6480464 Valproic Acid results in increased expression of VAMP8 mRNA CTD PMID:23179753 more ... vinclozolin affects expression ISO RGD:620421 6480464 vinclozolin affects the expression of VAMP8 mRNA CTD PMID:19015723 vinclozolin decreases expression ISO RGD:620421 6480464 vinclozolin results in decreased expression of VAMP8 mRNA CTD PMID:23034163 vorinostat increases expression ISO RGD:1347649 6480464 vorinostat results in increased expression of VAMP8 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:1347649 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of VAMP8 mRNA CTD PMID:27188386